Evidence map›Paper›PMID 26451324›Full record

ArticleOncoimmunology2015

Histamine deficiency promotes accumulation of immunosuppressive immature myeloid cells and growth of murine gliomas.

Brian Ahn, Gary Kohanbash, Takayuki Ohkuri, Akemi Kosaka, Xiaowei Chen, Maki Ikeura, Timothy C Wang, Hideho Okada

Open access · goldAbstract read
In one paragraph

Article in Oncoimmunology, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed
0.7field-weighted citation impact, top 31% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Article
  3. New Kids on the Block: Immature Myeloid Cells in Intestinal Regeneration.Cellular and molecular gastroenterology and hepatology · 2024
    Article
  4. Article
  5. Chronic Stress-Induced Gene ChangesFrontiers in oncology · 2021
    Article
  6. Review
  7. Review
  8. Article
  9. Review
  10. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 1 country.

Brian AhnDepartment of Neurological Surgery; University of Pittsburgh ; Pittsburgh, PA USA ; Department of Immunology; University of Pittsburgh ; Pittsburgh, PA USA.
Gary KohanbashDepartment of Neurological Surgery; University of Pittsburgh ; Pittsburgh, PA USA.
Takayuki OhkuriDepartment of Neurological Surgery; University of Pittsburgh ; Pittsburgh, PA USA.
Akemi KosakaDepartment of Neurological Surgery; University of Pittsburgh ; Pittsburgh, PA USA.
Xiaowei ChenDepartment of Pathology and Cell Biology; Columbia University ; New York, NY USA.
Maki IkeuraDepartment of Neurological Surgery; University of Pittsburgh ; Pittsburgh, PA USA.
Timothy C WangDivision of Digestive and Liver Diseases; Department of Medicine; Columbia University ; New York, NY USA.
Hideho OkadaDepartment of Neurological Surgery; University of Pittsburgh ; Pittsburgh, PA USA ; Department of Immunology; University of Pittsburgh ; Pittsburgh, PA USA ; Department of Surgery; University of Pittsburgh ; Pittsburgh, PA USA.
University of Pittsburgh · USColumbia University · US

Funding

VECTOR CORE FACILITYP30CA047904 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Jessie Nedrow · 1988 to 2026
$158.0M
Vector delivery to modify the brain tumor and its microenvironmentP01NS040923 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI GLORIOSO, JOSEPH C · 2002 to 2012
$12.7M
Training in Cellular & Molecular Mechanisms of Tumor RejectionT32CA082084 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI Robert J Binder, Dario AA Vignali · 1999 to 2026
$9.2M
Type-1 Antigen Presenting Cells in CNS Tumors - Key to Efficient Anti-Tumor T-CelP01CA132714 · NCI · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KALINSKI, PAWEL · 2009 to 2013
$6.8M
Novel Immunotherapy of Glioma using miR-17-92 Transfected T CellsR01NS055140 · NINDS · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI OKADA, HIDEHO · 2007 to 2015
$2.6M
Novel Modifiers of Toll-like and RIG-like Receptor SignalingU24AI082673 · NIAID · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI SARKAR, SAUMENDRA N · 2009 to 2013
$1.5M
NCI NIH HHS P01 CA132714NCI NIH HHS P30 CA047904NCI NIH HHS T32 CA082084NIAID NIH HHS U24 AI082673NINDS NIH HHS P01 NS040923NINDS NIH HHS R01 NS055140
6 · The paper itself

Abstract

To elucidate mechanisms underlying epidemiological findings of decreased risk of glioma development in patients with allergies and asthma, gliomas were induced in mice deficient for histidine decarboxylase (HDC), the enzyme responsible for histamine production. These mice exhibited shortened survival and enhanced tumor growth compared to wild-type (WT) mice. Previous studies have shown a pivotal role of HDC in maturation of bone marrow (BM)-derived myeloid cells. In our glioma models, brain-infiltrating leukocytes (BIL) demonstrated an increased frequency of CD11b

Indexed as

glioma, histamine, histidine decarboxylase, myeloid cells, prostaglandin E2

Identifiers

PMID26451324
PMCPMC4589044
OpenAlexW1698372424

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.